期刊论文详细信息
EMBO Molecular Medicine | |
uPA‐PAI‐1 heteromerization promotes breast cancer progression by attracting tumorigenic neutrophils | |
Christian Schulz1  Jörg Heil2  Matthias Mack3  Martin Canis4  Laura A Mittmann5  Constanze Braun5  Julian Dominik5  Bernd Uhl5  Christoph A Reichel5  Bojan Smiljanov5  Johanna B Schaubächer5  Florian Haring5  Lena Padovan5  Katja Steiger6  Wilko Weichert7  Kirsten Lauber8  Roman Hennel8  Ewgenija Gutjahr9  Peter Sinn9  Sandip M Kanse1,10  Markus Sperandio1,11  Robert Pick1,12  Fritz Krombach1,12  | |
[1] Department of Cardiology, University Hospital, Ludwig‐Maximilians‐Universität München, Munich, Germany;Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany;Department of Internal Medicine, University of Regensburg, Regensburg, Germany;Department of Otorhinolaryngology, University Hospital, Ludwig‐Maximilians‐Universität München, Munich, Germany;Department of Otorhinolaryngology, University Hospital, Ludwig‐Maximilians‐Universität München, Munich, Germany;Walter Brendel Centre of Experimental Medicine, University Hospital, Ludwig‐Maximilians‐Universität München, Munich, Germany;Department of Pathology, Technical University of Munich, Munich, Germany;Department of Pathology, Technical University of Munich, Munich, Germany;German Cancer Consortium (DKTK), partner site Munich, Ludwig‐Maximilians‐Universität München, Munich, Germany;Department of Radiation Oncology, University Hospital, Ludwig‐Maximilians‐Universität München, Munich, Germany;Institute for Pathology, University of Heidelberg, Heidelberg, Germany;Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway;Institute of Cardiovascular Physiology and Pathophysiology, Ludwig‐Maximilians‐Universität München, Munich, Germany;Walter Brendel Centre of Experimental Medicine, University Hospital, Ludwig‐Maximilians‐Universität München, Munich, Germany; | |
关键词: biomarker; breast cancer; fibrinolysis; innate immunity; neutrophils; | |
DOI : 10.15252/emmm.202013110 | |
来源: Wiley | |